-
EXCLUSIVE: Ketamine Therapy Leaders Share Bold Vision For Future At Benzinga's Psychedelics Capital Conference
Friday, April 14, 2023 - 11:36am | 755At the second edition of Benzinga’s Psychedelics Capital Conference, held in sunny Miami, leaders from four major ketamine therapy companies shared their optimistic insights and guidance about the industry. Revitalist L&W’s Kathryn Walker (OTC: RVLWF), Jeffrey Becker (Bexson...
-
New At-Home Multiple Drugs Formulation Delivery Technology Scores US Patent
Friday, September 16, 2022 - 12:08pm | 309SEVALENT, Bexson Biomedical’s disrupting offer ready for the small molecule injectable market, received patent allowance by the USPTO for “Complexing Agent Salt Formulations of Pharmaceutical Compounds.” The company’s formulation technology enables wearable, home...
-
EXCLUSIVE: Bexson Biomedical's CSO Says Subcutaneous Ketamine Could Treat Wide Range Of Health Issues
Wednesday, May 18, 2022 - 2:17pm | 718Bexson Biomedical recently signed a deal with the Stevanato Group to develop a subcutaneous delivery system of ketamine. “SG EZ-be Pod,” a wearable device designed for administering subcutaneous drugs, would facilitate patient administration of medications outside of clinics...
-
EXCLUSIVE: Bexson Biomedical Inks Agreement With Stevanato For Delivery System Of Ketamine In Pain Management
Thursday, April 28, 2022 - 8:00am | 329Bexson Biomedical, a private company in the psychedelics space, has inked a new agreement with Stevanato Group, an Italian-based provider of drug delivery solutions. Bexson is currently developing an improved version of ketamine called BB106, which allows for subcutaneous delivery of the drug. The...
-
Bexson Biomedical Closes $4.8M Series A Financing To Develop Wearable Ketamine Technology
Tuesday, February 2, 2021 - 9:42am | 493Pharmaceutical startup Bexson Biomedical confirmed Monday the closing an oversubscribed Series A funding round. The $4.8 million raise was led by Greyhouse Partners' Noetic Psychedelic Fund. Noetic advisor Warren Wright also agreed to join Bexson’s board of directors, supporting...